Latest News

 Filter by Provider

Cardinal Health raised FY25 EPS guidance after Q3 profit gains in key segments, while revenue slightly missed estimates amid contract expirations.

The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March.

Parker-Hannifin Corp (PH) stock gained after reporting mixed Q3 results and revising its 2025 outlook. Sales of $4.96B missed consensus, but EPS of $6.94 beat. Orders up 9% Y/Y with strong performance in Aerospace Systems. 2025 sales growth expected at 1% with EPS guidance of $26.60-$26.80. Dividend increased by 10%.

Wedbush Securities analyst Dan Ives raised his price target on Apple Inc. to $270, citing "incremental confidence" in the company's India supply chain strategy amid ongoing tariff concerns.

The market has finished positive for the month of May in 11 of the last 12 years. For an average return of 1.14%.

A discussion about how recent earnings, market reactions, and macro headlines are creating a short-term bullish environment—but one that remains fragile beneath the surface.

Church & Dwight (NYSE:CHD) shares dip after Q1 FY25 revenue fell 2.4% to $1.47B, missing the $1.51B estimate. Organic sales declined 1.2% due to lower volume. Gross profit dropped 3.9%, and operating income slipped 3.2%.

The company’s Q1 revenue missed estimates, and net profit declined due to higher staff costs and write-offs.

Harley-Davidson’s better-than-expected Q1 results and ongoing cost-cutting efforts offered some reassurance to investors despite concerns over weakening U.S. retail sales and long-term demand trends.

Economic signals are flashing recession. Yet tech refuses to play along.

Strategy Inc. (NASDAQ:MSTR) executive chairman Michael Saylor expressed optimism about the growing adoption of the Bitcoin standard among businesses on Thursday.

The shale oil producer lowered its full-year capital expenditure plan to a range of $5.8 billion to $6.2 billion, a $200 million reduction at the midpoint.

China’s spokesperson said if the U.S. wants to talk, it has to show sincerity and be prepared to correct its wrong practices and cancel the unilateral tariffs.

Organon shares sank 27% Thursday after slashing its dividend by over 90%, triggering analyst downgrades and investor concern. Some retail traders, however, remained upbeat, citing the company’s focus on debt reduction and long-term growth.

Social media platform, Reddit Inc. (NYSE: RDDT) is seeing strong commercial intent across its iconic comment threads, and it's now turning that engagement into ad revenue as part of a broader monetization push.

Nvidia CEO Jensen Huang warned U.S. lawmakers that export bans on AI chips may unintentionally benefit Huawei, allowing the Chinese tech giant to gain a competitive edge in the global AI race.

TransCode Therapeutics shares surged nearly 39% after reporting promising Phase 1a trial results for its metastatic cancer drug TTX-MC138, with strong retail interest and no major safety concerns.

The company said future earnings may be affected by many factors, such as tariffs and trade policies, currency fluctuations, and "recessionary fears."

Wall Street experienced a positive momentum as the S&P 500 marked its eighth consecutive day of gains on Thursday, climbing 0.6% to 5,604.14. This rally helped the index recover from losses incurred due to trade tariffs announced by President Donald Trump.

Although the S&P 500 was temporarily down -21% from the February peak, the index has now bounced back and is down only -5% for the year.

CEO Tim Cook said it would be very difficult to predict beyond the June quarter, adding that he was not sure what would happen with the tariffs.

Leading cryptocurrencies rallied Thursday as investors turned to Bitcoin amid a weak financial climate.

Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.

Apple CEO Tim Cook warned of a $900 million tariff impact in the June quarter as the company shifts production of iPhones, Macs, and iPads from China to India and Vietnam.

Strategy bought 301,335 BTC in Q1, raising the total to 528,185 BTC.

Cathie Wood's Ark Invest Makes Bold $9.8M Robinhood Bet While Dumping Palantir Ahead of Earnings.

25Q1 Y/Y earnings are expected to be 12.9%. Excluding the energy sector, the Y/Y earnings estimate is 14.9%.

Trump ousts national security adviser Mike Waltz amid internal tensions and a messaging scandal, naming him UN ambassador and replacing him temporarily with Secretary of State Marco Rubio.

The Nasdaq closed the day with net bullish technicals and beyond the likely retest of the April swing low.

Analysts raise ratings for Robinhood (HOOD) after strong Q1 earnings report. Quarterly revenue and EPS beat estimates, but concerns about market changes remain.

Major global indices remain in bullish Elliott Wave patterns, with growing confirmation across individual stocks.

Chinese investors responded as the RMB gold price recorded its strongest Q1 since 2002 when the Shanghai Gold Exchange (SGE) was established.

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.

Tesla and Elon Musk have denied a report that the EV giant was looking for a new CEO. A look at how prediction markets reacted to the report and who could replace Musk.

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

U.S. equity markets futures utterly collapsed into the close and went red.

Atlassian shares are tumbling in Thursday's after-hours session on the heels of the company's fiscal third-quarter results. Here's a look at the highlights from the quarter.